Literature DB >> 25296579

The phenotypic and molecular genetic spectrum of Alström syndrome in 44 Turkish kindreds and a literature review of Alström syndrome in Turkey.

Ayşegül Ozantürk1, Jan D Marshall2, Gayle B Collin2, Selma Düzenli3, Robert P Marshall4, Şükrü Candan5, Tülay Tos6, İhsan Esen7, Mustafa Taşkesen8, Atilla Çayır9, Şükrü Öztürk10, İhsan Üstün11, Esra Ataman12, Emin Karaca13, Taha Reşid Özdemir13, İlknur Erol14, Fehime Kara Eroğlu15, Deniz Torun16, Erhan Parıltay12, Elif Yılmaz-Güleç17, Ender Karaca17, M Emre Atabek18, Nursel Elçioğlu19, İlhan Satman20, Claes Möller21, Jean Muller22, Jürgen K Naggert2, Rıza Köksal Özgül1.   

Abstract

Alström syndrome (ALMS) is an autosomal recessive disease characterized by multiple organ involvement, including neurosensory vision and hearing loss, childhood obesity, diabetes mellitus, cardiomyopathy, hypogonadism, and pulmonary, hepatic, renal failure and systemic fibrosis. Alström Syndrome is caused by mutations in ALMS1, and ALMS1 protein is thought to have a role in microtubule organization, intraflagellar transport, endosome recycling and cell cycle regulation. Here, we report extensive phenotypic and genetic analysis of a large cohort of Turkish patients with ALMS. We evaluated 61 Turkish patients, including 11 previously reported, for both clinical spectrum and mutations in ALMS1. To reveal the molecular diagnosis of the patients, different approaches were used in combination, a cohort of patients were screened by the gene array to detect the common mutations in ALMS1 gene, then in patients having any of the common ALMS1 mutations were subjected to direct DNA sequencing or next-generation sequencing for the screening of mutations in all coding regions of the gene. In total, 20 distinct disease-causing nucleotide changes in ALMS1 have been identified, eight of which are novel, thereby increasing the reported ALMS1 mutations by 6% (8/120). Five disease-causing variants were identified in more than one kindred, but most of the alleles were unique to each single patient and identified only once (16/20). So far, 16 mutations identified were specific to the Turkish population, and four have also been reported in other ethnicities. In addition, 49 variants of uncertain pathogenicity were noted, and four of these were very rare and probably or likely deleterious according to in silico mutation prediction analyses. ALMS has a relatively high incidence in Turkey and the present study shows that the ALMS1 mutations are largely heterogeneous; thus, these data from a particular population may provide a unique source for the identification of additional mutations underlying Alström Syndrome and contribute to genotype-phenotype correlation studies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25296579      PMCID: PMC5460767          DOI: 10.1038/jhg.2014.85

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  36 in total

1.  Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alström syndrome.

Authors:  Tom Hearn; Glenn L Renforth; Cosma Spalluto; Neil A Hanley; Karen Piper; Sarah Brickwood; Chris White; Vincent Connolly; James F N Taylor; Isabelle Russell-Eggitt; Dominque Bonneau; Mark Walker; David I Wilson
Journal:  Nat Genet       Date:  2002-04-08       Impact factor: 38.330

2.  A novel ALMS1 splice mutation in a non-obese juvenile-onset insulin-dependent syndromic diabetic patient.

Authors:  May Sanyoura; Cédric Woudstra; George Halaby; Patrick Baz; Valérie Senée; Pierre-Jean Guillausseau; Pierre Zalloua; Cécile Julier
Journal:  Eur J Hum Genet       Date:  2013-05-08       Impact factor: 4.246

Review 3.  Genealogy, natural history, and phenotype of Alström syndrome in a large Acadian kindred and three additional families.

Authors:  J D Marshall; M D Ludman; S E Shea; S R Salisbury; S M Willi; R G LaRoche; P M Nishina
Journal:  Am J Med Genet       Date:  1997-12-12

4.  Evaluation of insulin resistant diabetes mellitus in Alström syndrome: a long-term prospective follow-up of three siblings.

Authors:  I Satman; M T Yilmaz; N Gürsoy; K Karşidağ; N Dinççağ; T Ovali; S Karadeniz; V Uysal; Z Buğra; A Okten; S Devrim
Journal:  Diabetes Res Clin Pract       Date:  2002-06       Impact factor: 5.602

5.  Centriolar association of ALMS1 and likely centrosomal functions of the ALMS motif-containing proteins C10orf90 and KIAA1731.

Authors:  Victoria J Knorz; Cosma Spalluto; Mark Lessard; Tracey L Purvis; Fiona F Adigun; Gayle B Collin; Neil A Hanley; David I Wilson; Thomas Hearn
Journal:  Mol Biol Cell       Date:  2010-09-15       Impact factor: 4.138

6.  Spectrum of ALMS1 variants and evaluation of genotype-phenotype correlations in Alström syndrome.

Authors:  Jan D Marshall; Elizabeth G Hinman; Gayle B Collin; Sebastian Beck; Rita Cerqueira; Pietro Maffei; Gabriella Milan; Weidong Zhang; David I Wilson; Tom Hearn; Purificação Tavares; Roberto Vettor; Caterina Veronese; Mitchell Martin; W Venus So; Patsy M Nishina; Jürgen K Naggert
Journal:  Hum Mutat       Date:  2007-11       Impact factor: 4.878

7.  Targeted high-throughput sequencing for diagnosis of genetically heterogeneous diseases: efficient mutation detection in Bardet-Biedl and Alström syndromes.

Authors:  Claire Redin; Stéphanie Le Gras; Oussema Mhamdi; Véronique Geoffroy; Corinne Stoetzel; Marie-Claire Vincent; Pietro Chiurazzi; Didier Lacombe; Ines Ouertani; Florence Petit; Marianne Till; Alain Verloes; Bernard Jost; Habiba Bouhamed Chaabouni; Helene Dollfus; Jean-Louis Mandel; Jean Muller
Journal:  J Med Genet       Date:  2012-07-07       Impact factor: 6.318

8.  Metabolic syndrome features presenting in early childhood in Alström syndrome: a case report.

Authors:  Özgür Pirgon; Mehmet Emre Atabek; Ilhan Asya Tanju
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-11-06

9.  Alström syndrome: genetics and clinical overview.

Authors:  Jan D Marshall; Pietro Maffei; Gayle B Collin; Jürgen K Naggert
Journal:  Curr Genomics       Date:  2011-05       Impact factor: 2.236

10.  Mutations in Alström protein impair terminal differentiation of cardiomyocytes.

Authors:  Lincoln T Shenje; Peter Andersen; Marc K Halushka; Cecillia Lui; Laviel Fernandez; Gayle B Collin; Nuria Amat-Alarcon; Wendy Meschino; Ernest Cutz; Kenneth Chang; Raluca Yonescu; Denise A S Batista; Yan Chen; Stephen Chelko; Jane E Crosson; Janet Scheel; Luca Vricella; Brian D Craig; Beth A Marosy; David W Mohr; Kurt N Hetrick; Jane M Romm; Alan F Scott; David Valle; Jürgen K Naggert; Chulan Kwon; Kimberly F Doheny; Daniel P Judge
Journal:  Nat Commun       Date:  2014-03-04       Impact factor: 14.919

View more
  17 in total

1.  Alström Syndrome: Mutation Spectrum of ALMS1.

Authors:  Jan D Marshall; Jean Muller; Gayle B Collin; Gabriella Milan; Stephen F Kingsmore; Darrell Dinwiddie; Emily G Farrow; Neil A Miller; Francesca Favaretto; Pietro Maffei; Hélène Dollfus; Roberto Vettor; Jürgen K Naggert
Journal:  Hum Mutat       Date:  2015-05-18       Impact factor: 4.878

2.  Whole-exome sequencing establishes a diagnosis of Alstrom syndrome: a case report.

Authors:  Ziqin Liu; Xiaobo Chen
Journal:  Transl Pediatr       Date:  2022-04

3.  Comprehensive Endocrine-Metabolic Evaluation of Patients With Alström Syndrome Compared With BMI-Matched Controls.

Authors:  Joan C Han; Daniela P Reyes-Capo; Chia-Ying Liu; James C Reynolds; Evrim Turkbey; Ismail Baris Turkbey; Joy Bryant; Jan D Marshall; Jürgen K Naggert; William A Gahl; Jack A Yanovski; Meral Gunay-Aygun
Journal:  J Clin Endocrinol Metab       Date:  2018-07-01       Impact factor: 5.958

Review 4.  ALMS1 and Alström syndrome: a recessive form of metabolic, neurosensory and cardiac deficits.

Authors:  Tom Hearn
Journal:  J Mol Med (Berl)       Date:  2018-11-12       Impact factor: 4.599

5.  A case report of two siblings with Alstrom syndrome without hearing loss associated with two new ALMS1 variants.

Authors:  Maria F Shurygina; Maria A Parker; Catie L Schlechter; Rui Chen; Yumei Li; Richard G Weleber; Paul Yang; Mark E Pennesi
Journal:  BMC Ophthalmol       Date:  2019-12-07       Impact factor: 2.209

6.  Rare coding variants and X-linked loci associated with age at menarche.

Authors:  Kathryn L Lunetta; Felix R Day; Patrick Sulem; Katherine S Ruth; Joyce Y Tung; David A Hinds; Tõnu Esko; Cathy E Elks; Elisabeth Altmaier; Chunyan He; Jennifer E Huffman; Evelin Mihailov; Eleonora Porcu; Antonietta Robino; Lynda M Rose; Ursula M Schick; Lisette Stolk; Alexander Teumer; Deborah J Thompson; Michela Traglia; Carol A Wang; Laura M Yerges-Armstrong; Antonis C Antoniou; Caterina Barbieri; Andrea D Coviello; Francesco Cucca; Ellen W Demerath; Alison M Dunning; Ilaria Gandin; Megan L Grove; Daniel F Gudbjartsson; Lynne J Hocking; Albert Hofman; Jinyan Huang; Rebecca D Jackson; David Karasik; Jennifer Kriebel; Ethan M Lange; Leslie A Lange; Claudia Langenberg; Xin Li; Jian'an Luan; Reedik Mägi; Alanna C Morrison; Sandosh Padmanabhan; Ailith Pirie; Ozren Polasek; David Porteous; Alex P Reiner; Fernando Rivadeneira; Igor Rudan; Cinzia F Sala; David Schlessinger; Robert A Scott; Doris Stöckl; Jenny A Visser; Uwe Völker; Diego Vozzi; James G Wilson; Marek Zygmunt; Eric Boerwinkle; Julie E Buring; Laura Crisponi; Douglas F Easton; Caroline Hayward; Frank B Hu; Simin Liu; Andres Metspalu; Craig E Pennell; Paul M Ridker; Konstantin Strauch; Elizabeth A Streeten; Daniela Toniolo; André G Uitterlinden; Sheila Ulivi; Henry Völzke; Nicholas J Wareham; Melissa Wellons; Nora Franceschini; Daniel I Chasman; Unnur Thorsteinsdottir; Anna Murray; Kari Stefansson; Joanne M Murabito; Ken K Ong; John R B Perry
Journal:  Nat Commun       Date:  2015-08-04       Impact factor: 14.919

Review 7.  Alström syndrome: current perspectives.

Authors:  María Álvarez-Satta; Sheila Castro-Sánchez; Diana Valverde
Journal:  Appl Clin Genet       Date:  2015-07-21

8.  Novel Mutations in Two Saudi Patients with Congenital Retinal Dystrophy.

Authors:  Leen Abu Safieh; Humoud M Al-Otaibi; Richard Alan Lewis; Igor Kozak
Journal:  Middle East Afr J Ophthalmol       Date:  2016 Jan-Mar

9.  Rare Compound Heterozygous Frameshift Mutations in ALMS1 Gene Identified Through Exome Sequencing in a Taiwanese Patient With Alström Syndrome.

Authors:  Meng-Che Tsai; Hui-Wen Yu; Tsunglin Liu; Yen-Yin Chou; Yuan-Yow Chiou; Peng-Chieh Chen
Journal:  Front Genet       Date:  2018-04-18       Impact factor: 4.599

10.  Whole exome sequencing identifies rare biallelic ALMS1 missense and stop gain mutations in familial Alström syndrome patients.

Authors:  Naglaa M Kamal; Ahmed N Sahly; Babajan Banaganapalli; Omran M Rashidi; Preetha J Shetty; Jumana Y Al-Aama; Noor A Shaik; Ramu Elango; Omar I Saadah
Journal:  Saudi J Biol Sci       Date:  2019-09-11       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.